Menthol, or menthol insulin, and glyburide include glyburide R, glyburide N, and premixed insulin. Glycopyrrolin R is generically known as Recombinant Human Insulin Injection, Glycopyrrolin N is generically known as Low-Arginine Recombinant Human Insulin Injection, and Premixed Insulin is generically known as 30/70 Mixed Recombinant Human Insulin Injection. Since the uses are not exactly the same, there is no claim as to which one is better. Mentholated insulin is mainly used for the treatment of all types of diabetes mellitus and various acute or severe complications of diabetes mellitus, among others. Mentholated insulin is a fast-acting insulin, which mainly binds to the insulin receptor, thus exerting a hypoglycemic effect. Adverse effects of Mentholatum insulin are hypoglycemia, urticaria, and rash. It is contraindicated in hypoglycemia and in patients who are allergic to Mentholatum insulin. Recombinant Human Insulin Injection, Low-Arginine Recombinant Human Insulin Injection can be used in the treatment of type 1 or type 2 diabetes. Premixed insulin may be used for the treatment of type 2 diabetes. It is contraindicated in people with hypoglycemia, hypersensitivity to human insulin and any of its components. Adverse reactions are hypoglycemia, dyspnea, etc. The use of insulin should pay attention to regular review in the hospital, timely testing of blood glucose, and adjust the dosage of insulin under the guidance of the doctor.